nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—Blood pressure systolic increased—Sorafenib—liver cancer	0.0763	0.191	CcSEcCtD
Amphetamine—L-Phenylalanine—TAT—liver cancer	0.0143	0.367	CrCbGaD
Amphetamine—Blood pressure increased—Sorafenib—liver cancer	0.0111	0.0278	CcSEcCtD
Amphetamine—Cardiomyopathy—Epirubicin—liver cancer	0.00799	0.0201	CcSEcCtD
Amphetamine—Pseudoephedrine—IL2—liver cancer	0.0079	0.203	CrCbGaD
Amphetamine—Mood swings—Sorafenib—liver cancer	0.00761	0.0191	CcSEcCtD
Amphetamine—Cardiomyopathy—Doxorubicin—liver cancer	0.0074	0.0186	CcSEcCtD
Amphetamine—Abdominal pain upper—Sorafenib—liver cancer	0.00734	0.0184	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00723	0.0181	CcSEcCtD
Amphetamine—Erectile dysfunction—Sorafenib—liver cancer	0.0064	0.016	CcSEcCtD
Amphetamine—Weight decreased—Sorafenib—liver cancer	0.00628	0.0158	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00614	0.0154	CcSEcCtD
Amphetamine—Acute coronary syndrome—Sorafenib—liver cancer	0.0061	0.0153	CcSEcCtD
Amphetamine—Myocardial infarction—Sorafenib—liver cancer	0.00607	0.0152	CcSEcCtD
Amphetamine—Erythema multiforme—Sorafenib—liver cancer	0.00525	0.0132	CcSEcCtD
Amphetamine—Viral infection—Epirubicin—liver cancer	0.00453	0.0114	CcSEcCtD
Amphetamine—Angioedema—Sorafenib—liver cancer	0.00442	0.0111	CcSEcCtD
Amphetamine—Dyskinesia—Epirubicin—liver cancer	0.00435	0.0109	CcSEcCtD
Amphetamine—Viral infection—Doxorubicin—liver cancer	0.00419	0.0105	CcSEcCtD
Amphetamine—Hypertension—Sorafenib—liver cancer	0.00418	0.0105	CcSEcCtD
Amphetamine—Dry mouth—Sorafenib—liver cancer	0.00403	0.0101	CcSEcCtD
Amphetamine—Dyskinesia—Doxorubicin—liver cancer	0.00403	0.0101	CcSEcCtD
Amphetamine—Anaphylactic shock—Sorafenib—liver cancer	0.00395	0.00991	CcSEcCtD
Amphetamine—Infection—Sorafenib—liver cancer	0.00392	0.00984	CcSEcCtD
Amphetamine—Anorexia—Sorafenib—liver cancer	0.00376	0.00944	CcSEcCtD
Amphetamine—Dyspnoea—Sorafenib—liver cancer	0.00352	0.00883	CcSEcCtD
Amphetamine—Dyspepsia—Sorafenib—liver cancer	0.00348	0.00872	CcSEcCtD
Amphetamine—Decreased appetite—Sorafenib—liver cancer	0.00343	0.00861	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00341	0.00855	CcSEcCtD
Amphetamine—Fatigue—Sorafenib—liver cancer	0.0034	0.00854	CcSEcCtD
Amphetamine—Constipation—Sorafenib—liver cancer	0.00338	0.00847	CcSEcCtD
Amphetamine—Gastrointestinal pain—Sorafenib—liver cancer	0.00323	0.0081	CcSEcCtD
Amphetamine—Urticaria—Sorafenib—liver cancer	0.00314	0.00787	CcSEcCtD
Amphetamine—Body temperature increased—Sorafenib—liver cancer	0.00312	0.00783	CcSEcCtD
Amphetamine—Abdominal pain—Sorafenib—liver cancer	0.00312	0.00783	CcSEcCtD
Amphetamine—Cerebrovascular accident—Epirubicin—liver cancer	0.00303	0.0076	CcSEcCtD
Amphetamine—Affect lability—Epirubicin—liver cancer	0.00292	0.00733	CcSEcCtD
Amphetamine—Hypersensitivity—Sorafenib—liver cancer	0.00291	0.0073	CcSEcCtD
Amphetamine—Asthenia—Sorafenib—liver cancer	0.00283	0.00711	CcSEcCtD
Amphetamine—Mood swings—Epirubicin—liver cancer	0.00281	0.00706	CcSEcCtD
Amphetamine—Cerebrovascular accident—Doxorubicin—liver cancer	0.0028	0.00703	CcSEcCtD
Amphetamine—Abdominal pain upper—Epirubicin—liver cancer	0.00271	0.0068	CcSEcCtD
Amphetamine—Affect lability—Doxorubicin—liver cancer	0.0027	0.00678	CcSEcCtD
Amphetamine—Diarrhoea—Sorafenib—liver cancer	0.0027	0.00678	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00267	0.00671	CcSEcCtD
Amphetamine—Pseudoephedrine—TNF—liver cancer	0.00267	0.0684	CrCbGaD
Amphetamine—Nateglinide—PPARG—liver cancer	0.00262	0.0671	CrCbGaD
Amphetamine—Dizziness—Sorafenib—liver cancer	0.00261	0.00655	CcSEcCtD
Amphetamine—Mood swings—Doxorubicin—liver cancer	0.0026	0.00653	CcSEcCtD
Amphetamine—Tranylcypromine—CYP2E1—liver cancer	0.00259	0.0663	CrCbGaD
Amphetamine—Vomiting—Sorafenib—liver cancer	0.00251	0.0063	CcSEcCtD
Amphetamine—Abdominal pain upper—Doxorubicin—liver cancer	0.00251	0.00629	CcSEcCtD
Amphetamine—Rash—Sorafenib—liver cancer	0.00249	0.00625	CcSEcCtD
Amphetamine—Dermatitis—Sorafenib—liver cancer	0.00249	0.00624	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00247	0.00621	CcSEcCtD
Amphetamine—Headache—Sorafenib—liver cancer	0.00247	0.00621	CcSEcCtD
Amphetamine—Nausea—Sorafenib—liver cancer	0.00235	0.00588	CcSEcCtD
Amphetamine—Photosensitivity reaction—Epirubicin—liver cancer	0.00234	0.00588	CcSEcCtD
Amphetamine—Weight decreased—Epirubicin—liver cancer	0.00232	0.00582	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00227	0.00569	CcSEcCtD
Amphetamine—Urinary tract infection—Epirubicin—liver cancer	0.00222	0.00558	CcSEcCtD
Amphetamine—Sweating—Epirubicin—liver cancer	0.00219	0.0055	CcSEcCtD
Amphetamine—Photosensitivity reaction—Doxorubicin—liver cancer	0.00217	0.00544	CcSEcCtD
Amphetamine—Weight decreased—Doxorubicin—liver cancer	0.00215	0.00539	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.0021	0.00527	CcSEcCtD
Amphetamine—Benzyl alcohol—CYP2E1—liver cancer	0.00209	0.0536	CrCbGaD
Amphetamine—Benzyl alcohol—CYP1A1—liver cancer	0.00206	0.0529	CrCbGaD
Amphetamine—Urinary tract infection—Doxorubicin—liver cancer	0.00206	0.00516	CcSEcCtD
Amphetamine—Sweating—Doxorubicin—liver cancer	0.00203	0.00509	CcSEcCtD
Amphetamine—Selegiline—CYP2E1—liver cancer	0.00201	0.0514	CrCbGaD
Amphetamine—Erythema multiforme—Epirubicin—liver cancer	0.00194	0.00487	CcSEcCtD
Amphetamine—Erythema multiforme—Doxorubicin—liver cancer	0.0018	0.00451	CcSEcCtD
Amphetamine—Phenelzine—CYP2E1—liver cancer	0.00177	0.0453	CrCbGaD
Amphetamine—Tension—Epirubicin—liver cancer	0.00175	0.0044	CcSEcCtD
Amphetamine—Nervousness—Epirubicin—liver cancer	0.00174	0.00436	CcSEcCtD
Amphetamine—Agitation—Epirubicin—liver cancer	0.00164	0.00412	CcSEcCtD
Amphetamine—Tension—Doxorubicin—liver cancer	0.00162	0.00407	CcSEcCtD
Amphetamine—Nervousness—Doxorubicin—liver cancer	0.00161	0.00403	CcSEcCtD
Amphetamine—Palpitations—Epirubicin—liver cancer	0.00158	0.00396	CcSEcCtD
Amphetamine—Convulsion—Epirubicin—liver cancer	0.00155	0.00389	CcSEcCtD
Amphetamine—Hypertension—Epirubicin—liver cancer	0.00154	0.00387	CcSEcCtD
Amphetamine—Chest pain—Epirubicin—liver cancer	0.00152	0.00382	CcSEcCtD
Amphetamine—Agitation—Doxorubicin—liver cancer	0.00152	0.00381	CcSEcCtD
Amphetamine—Anxiety—Epirubicin—liver cancer	0.00152	0.00381	CcSEcCtD
Amphetamine—Dry mouth—Epirubicin—liver cancer	0.00149	0.00373	CcSEcCtD
Amphetamine—Palpitations—Doxorubicin—liver cancer	0.00146	0.00367	CcSEcCtD
Amphetamine—Anaphylactic shock—Epirubicin—liver cancer	0.00146	0.00366	CcSEcCtD
Amphetamine—Infection—Epirubicin—liver cancer	0.00145	0.00364	CcSEcCtD
Amphetamine—Convulsion—Doxorubicin—liver cancer	0.00143	0.0036	CcSEcCtD
Amphetamine—Hypertension—Doxorubicin—liver cancer	0.00143	0.00358	CcSEcCtD
Amphetamine—Tachycardia—Epirubicin—liver cancer	0.00142	0.00357	CcSEcCtD
Amphetamine—Hyperhidrosis—Epirubicin—liver cancer	0.00141	0.00354	CcSEcCtD
Amphetamine—Chest pain—Doxorubicin—liver cancer	0.00141	0.00353	CcSEcCtD
Amphetamine—Anxiety—Doxorubicin—liver cancer	0.0014	0.00352	CcSEcCtD
Amphetamine—Anorexia—Epirubicin—liver cancer	0.00139	0.00349	CcSEcCtD
Amphetamine—Dry mouth—Doxorubicin—liver cancer	0.00138	0.00346	CcSEcCtD
Amphetamine—Anaphylactic shock—Doxorubicin—liver cancer	0.00135	0.00339	CcSEcCtD
Amphetamine—Infection—Doxorubicin—liver cancer	0.00134	0.00337	CcSEcCtD
Amphetamine—Insomnia—Epirubicin—liver cancer	0.00132	0.00331	CcSEcCtD
Amphetamine—Tachycardia—Doxorubicin—liver cancer	0.00132	0.00331	CcSEcCtD
Amphetamine—Hyperhidrosis—Doxorubicin—liver cancer	0.00131	0.00327	CcSEcCtD
Amphetamine—Dyspnoea—Epirubicin—liver cancer	0.0013	0.00326	CcSEcCtD
Amphetamine—Somnolence—Epirubicin—liver cancer	0.0013	0.00325	CcSEcCtD
Amphetamine—Anorexia—Doxorubicin—liver cancer	0.00129	0.00323	CcSEcCtD
Amphetamine—Dyspepsia—Epirubicin—liver cancer	0.00128	0.00322	CcSEcCtD
Amphetamine—Decreased appetite—Epirubicin—liver cancer	0.00127	0.00318	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00126	0.00316	CcSEcCtD
Amphetamine—Fatigue—Epirubicin—liver cancer	0.00126	0.00316	CcSEcCtD
Amphetamine—Constipation—Epirubicin—liver cancer	0.00125	0.00313	CcSEcCtD
Amphetamine—Insomnia—Doxorubicin—liver cancer	0.00122	0.00306	CcSEcCtD
Amphetamine—Dyspnoea—Doxorubicin—liver cancer	0.0012	0.00302	CcSEcCtD
Amphetamine—Somnolence—Doxorubicin—liver cancer	0.0012	0.00301	CcSEcCtD
Amphetamine—Gastrointestinal pain—Epirubicin—liver cancer	0.00119	0.00299	CcSEcCtD
Amphetamine—Dyspepsia—Doxorubicin—liver cancer	0.00119	0.00298	CcSEcCtD
Amphetamine—Decreased appetite—Doxorubicin—liver cancer	0.00117	0.00294	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00117	0.00292	CcSEcCtD
Amphetamine—Fatigue—Doxorubicin—liver cancer	0.00116	0.00292	CcSEcCtD
Amphetamine—Urticaria—Epirubicin—liver cancer	0.00116	0.00291	CcSEcCtD
Amphetamine—Constipation—Doxorubicin—liver cancer	0.00115	0.0029	CcSEcCtD
Amphetamine—Body temperature increased—Epirubicin—liver cancer	0.00115	0.00289	CcSEcCtD
Amphetamine—Abdominal pain—Epirubicin—liver cancer	0.00115	0.00289	CcSEcCtD
Amphetamine—Gastrointestinal pain—Doxorubicin—liver cancer	0.0011	0.00277	CcSEcCtD
Amphetamine—Hypersensitivity—Epirubicin—liver cancer	0.00108	0.0027	CcSEcCtD
Amphetamine—Urticaria—Doxorubicin—liver cancer	0.00107	0.00269	CcSEcCtD
Amphetamine—Abdominal pain—Doxorubicin—liver cancer	0.00107	0.00268	CcSEcCtD
Amphetamine—Body temperature increased—Doxorubicin—liver cancer	0.00107	0.00268	CcSEcCtD
Amphetamine—Asthenia—Epirubicin—liver cancer	0.00105	0.00263	CcSEcCtD
Amphetamine—Diarrhoea—Epirubicin—liver cancer	0.000998	0.0025	CcSEcCtD
Amphetamine—Hypersensitivity—Doxorubicin—liver cancer	0.000995	0.0025	CcSEcCtD
Amphetamine—Nateglinide—ALB—liver cancer	0.000985	0.0253	CrCbGaD
Amphetamine—Asthenia—Doxorubicin—liver cancer	0.000969	0.00243	CcSEcCtD
Amphetamine—Dizziness—Epirubicin—liver cancer	0.000965	0.00242	CcSEcCtD
Amphetamine—Vomiting—Epirubicin—liver cancer	0.000928	0.00233	CcSEcCtD
Amphetamine—Diarrhoea—Doxorubicin—liver cancer	0.000924	0.00232	CcSEcCtD
Amphetamine—Rash—Epirubicin—liver cancer	0.00092	0.00231	CcSEcCtD
Amphetamine—Dermatitis—Epirubicin—liver cancer	0.000919	0.00231	CcSEcCtD
Amphetamine—Headache—Epirubicin—liver cancer	0.000914	0.00229	CcSEcCtD
Amphetamine—Dizziness—Doxorubicin—liver cancer	0.000893	0.00224	CcSEcCtD
Amphetamine—Nausea—Epirubicin—liver cancer	0.000867	0.00217	CcSEcCtD
Amphetamine—Vomiting—Doxorubicin—liver cancer	0.000858	0.00215	CcSEcCtD
Amphetamine—Rash—Doxorubicin—liver cancer	0.000851	0.00214	CcSEcCtD
Amphetamine—Dermatitis—Doxorubicin—liver cancer	0.000851	0.00213	CcSEcCtD
Amphetamine—Headache—Doxorubicin—liver cancer	0.000846	0.00212	CcSEcCtD
Amphetamine—Nausea—Doxorubicin—liver cancer	0.000802	0.00201	CcSEcCtD
Amphetamine—SLC22A3—Metabolism—CRABP1—liver cancer	0.000311	0.000554	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000311	0.000554	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—PPARA—liver cancer	0.00031	0.000552	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—SERPINE1—liver cancer	0.00031	0.000552	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000306	0.000543	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000301	0.000535	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.0003	0.000533	CbGpPWpGaD
Amphetamine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000297	0.000528	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL6—liver cancer	0.000295	0.000525	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL2—liver cancer	0.000295	0.000525	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TERT—liver cancer	0.000294	0.000523	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—TRIO—liver cancer	0.000294	0.000522	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PSMD10—liver cancer	0.000287	0.00051	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PSMA4—liver cancer	0.000287	0.00051	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCR4—liver cancer	0.000282	0.000501	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GOT2—liver cancer	0.000279	0.000496	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—HPGDS—liver cancer	0.000272	0.000484	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KDR—liver cancer	0.000269	0.000478	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—RAF1—liver cancer	0.000268	0.000477	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—liver cancer	0.000268	0.000476	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAPK14—liver cancer	0.000267	0.000475	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TRIO—liver cancer	0.000267	0.000474	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000266	0.000472	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TP53—liver cancer	0.000264	0.000469	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—TGFB1—liver cancer	0.000263	0.000468	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP2E1—liver cancer	0.000262	0.000466	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ESR1—liver cancer	0.000262	0.000466	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000262	0.000465	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—F2—liver cancer	0.000259	0.00046	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR4—liver cancer	0.000256	0.000455	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CG—liver cancer	0.000248	0.000441	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—APC—liver cancer	0.000248	0.000441	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—HRAS—liver cancer	0.000248	0.000441	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYCS—liver cancer	0.000245	0.000436	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—JUN—liver cancer	0.000244	0.000434	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CPT1B—liver cancer	0.000243	0.000432	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GLUL—liver cancer	0.000243	0.000432	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PSMD10—liver cancer	0.000243	0.000431	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PSMA4—liver cancer	0.000243	0.000431	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000242	0.000431	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000242	0.00043	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—IL6—liver cancer	0.000241	0.000429	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GOT1—liver cancer	0.000241	0.000428	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GGT1—liver cancer	0.000241	0.000428	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GOT2—liver cancer	0.000236	0.00042	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NR1H4—liver cancer	0.000235	0.000417	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—BRAF—liver cancer	0.000233	0.000414	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—liver cancer	0.000231	0.000411	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—MAPK8—liver cancer	0.000231	0.000411	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—liver cancer	0.000231	0.00041	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTA3—liver cancer	0.000231	0.00041	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—UGDH—liver cancer	0.000225	0.0004	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP2E1—liver cancer	0.000222	0.000395	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CD—liver cancer	0.000218	0.000387	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GSTP1—liver cancer	0.000216	0.000385	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—PIK3CA—liver cancer	0.000216	0.000384	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SERPINE1—liver cancer	0.000215	0.000383	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000215	0.000382	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—HMOX1—liver cancer	0.000213	0.000379	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—KRAS—liver cancer	0.000213	0.000379	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SHC3—liver cancer	0.000213	0.000378	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—EPT1—liver cancer	0.000212	0.000376	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTA4—liver cancer	0.000211	0.000375	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000209	0.000372	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—RAF1—liver cancer	0.000209	0.000371	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYCS—liver cancer	0.000208	0.000369	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTA2—liver cancer	0.000206	0.000365	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GGT1—liver cancer	0.000204	0.000362	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GOT1—liver cancer	0.000204	0.000362	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TAT—liver cancer	0.000201	0.000357	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—F2—liver cancer	0.000199	0.000354	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GSTM1—liver cancer	0.000199	0.000353	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTA1—liver cancer	0.000198	0.000353	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NAT2—liver cancer	0.000196	0.000349	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PIK3CA—liver cancer	0.000196	0.000348	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—RAF1—liver cancer	0.000194	0.000346	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—liver cancer	0.000193	0.000343	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MTOR—liver cancer	0.00019	0.000338	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CB—liver cancer	0.00019	0.000338	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP1A1—liver cancer	0.000188	0.000335	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALDOB—liver cancer	0.000188	0.000334	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GSTP1—liver cancer	0.000183	0.000325	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HRAS—liver cancer	0.000181	0.000322	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—HMOX1—liver cancer	0.00018	0.000321	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—liver cancer	0.00018	0.00032	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CRABP1—liver cancer	0.000179	0.000319	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CDKN1B—liver cancer	0.000178	0.000317	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—AKT1—liver cancer	0.000176	0.000313	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MTHFR—liver cancer	0.000176	0.000312	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CASP3—liver cancer	0.000175	0.000311	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL2—liver cancer	0.000174	0.00031	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL6—liver cancer	0.000174	0.000309	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARA—liver cancer	0.000172	0.000306	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCND1—liver cancer	0.00017	0.000302	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—JUN—liver cancer	0.00017	0.000302	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CTNNB1—liver cancer	0.000168	0.000299	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GSTM1—liver cancer	0.000168	0.000299	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FST—liver cancer	0.000165	0.000294	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MMP9—liver cancer	0.000165	0.000293	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CDKN1A—liver cancer	0.000164	0.000292	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000163	0.000289	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PRKCE—liver cancer	0.000162	0.000288	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TP53—liver cancer	0.000161	0.000287	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAPK8—liver cancer	0.000161	0.000285	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—AKT1—liver cancer	0.00016	0.000285	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—liver cancer	0.000159	0.000284	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP1A1—liver cancer	0.000159	0.000283	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TRIO—liver cancer	0.000158	0.00028	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HPGDS—liver cancer	0.000157	0.000279	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR4—liver cancer	0.000151	0.000269	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MTHFR—liver cancer	0.000149	0.000264	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—VEGFA—liver cancer	0.000148	0.000264	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—HRAS—liver cancer	0.000148	0.000263	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CG—liver cancer	0.000148	0.000262	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—IL6—liver cancer	0.000148	0.000262	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PRKCE—liver cancer	0.000147	0.000262	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—STAT3—liver cancer	0.000147	0.000261	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARA—liver cancer	0.000146	0.000259	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000144	0.000256	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CSF2—liver cancer	0.000143	0.000255	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARG—liver cancer	0.000142	0.000253	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PSMD10—liver cancer	0.00014	0.000248	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PSMA4—liver cancer	0.00014	0.000248	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CPT1B—liver cancer	0.000136	0.000243	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GLUL—liver cancer	0.000136	0.000243	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MYC—liver cancer	0.000136	0.000242	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—liver cancer	0.000136	0.000242	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT2—liver cancer	0.000136	0.000242	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NR1H4—liver cancer	0.000132	0.000234	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CSF2—liver cancer	0.00013	0.000232	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CD—liver cancer	0.00013	0.000231	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTA3—liver cancer	0.000129	0.00023	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—liver cancer	0.000128	0.000228	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP2E1—liver cancer	0.000128	0.000227	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KRAS—liver cancer	0.000126	0.000224	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CG—liver cancer	0.000125	0.000222	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARG—liver cancer	0.000121	0.000214	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYCS—liver cancer	0.00012	0.000213	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADAM17—liver cancer	0.000119	0.000212	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTA4—liver cancer	0.000118	0.00021	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GGT1—liver cancer	0.000117	0.000209	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT1—liver cancer	0.000117	0.000209	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CA—liver cancer	0.000116	0.000206	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTA2—liver cancer	0.000115	0.000205	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CB—liver cancer	0.000113	0.000201	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—F2—liver cancer	0.000113	0.0002	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PSMA4—liver cancer	0.000112	0.0002	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PSMD10—liver cancer	0.000112	0.0002	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TP53—liver cancer	0.000112	0.000199	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTA1—liver cancer	0.000111	0.000198	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NAT2—liver cancer	0.00011	0.000195	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CD—liver cancer	0.00011	0.000195	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—liver cancer	0.000108	0.000193	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CG—liver cancer	0.000108	0.000192	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HRAS—liver cancer	0.000107	0.00019	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALDOB—liver cancer	0.000105	0.000187	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTP1—liver cancer	0.000105	0.000187	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HMOX1—liver cancer	0.000104	0.000185	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—liver cancer	0.000103	0.000182	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—F2—liver cancer	0.000102	0.000182	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CRABP1—liver cancer	0.000101	0.000179	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CG—liver cancer	9.78e-05	0.000174	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTM1—liver cancer	9.68e-05	0.000172	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CB—liver cancer	9.57e-05	0.00017	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CD—liver cancer	9.47e-05	0.000168	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AKT1—liver cancer	9.46e-05	0.000168	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP1A1—liver cancer	9.18e-05	0.000163	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HPGDS—liver cancer	8.79e-05	0.000156	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCE—liver cancer	8.7e-05	0.000155	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CD—liver cancer	8.6e-05	0.000153	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—liver cancer	8.56e-05	0.000152	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARA—liver cancer	8.4e-05	0.000149	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CB—liver cancer	8.26e-05	0.000147	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF2—liver cancer	8.24e-05	0.000147	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PSMD10—liver cancer	7.83e-05	0.000139	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PSMA4—liver cancer	7.83e-05	0.000139	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CSF2—liver cancer	7.7e-05	0.000137	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—RAF1—liver cancer	7.68e-05	0.000137	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT2—liver cancer	7.62e-05	0.000135	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—H2AFX—liver cancer	7.59e-05	0.000135	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—IL2—liver cancer	7.58e-05	0.000135	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CB—liver cancer	7.5e-05	0.000133	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CG—liver cancer	7.19e-05	0.000128	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2E1—liver cancer	7.16e-05	0.000127	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARG—liver cancer	6.94e-05	0.000123	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CA—liver cancer	6.89e-05	0.000123	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL2—liver cancer	6.88e-05	0.000122	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TERT—liver cancer	6.86e-05	0.000122	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYCS—liver cancer	6.7e-05	0.000119	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GGT1—liver cancer	6.58e-05	0.000117	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT1—liver cancer	6.58e-05	0.000117	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CD—liver cancer	6.32e-05	0.000112	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KDR—liver cancer	6.27e-05	0.000112	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—liver cancer	6.24e-05	0.000111	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK14—liver cancer	6.23e-05	0.000111	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ESR1—liver cancer	6.11e-05	0.000109	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—F2—liver cancer	6.04e-05	0.000107	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTP1—liver cancer	5.91e-05	0.000105	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CA—liver cancer	5.83e-05	0.000104	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMOX1—liver cancer	5.83e-05	0.000104	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APC—liver cancer	5.78e-05	0.000103	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CG—liver cancer	5.78e-05	0.000103	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AKT1—liver cancer	5.63e-05	0.0001	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CB—liver cancer	5.51e-05	9.8e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BRAF—liver cancer	5.43e-05	9.66e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTM1—liver cancer	5.43e-05	9.65e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP1A1—liver cancer	5.15e-05	9.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CD—liver cancer	5.08e-05	9.03e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CA—liver cancer	5.03e-05	8.95e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SERPINE1—liver cancer	5.03e-05	8.94e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—KRAS—liver cancer	4.97e-05	8.84e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—liver cancer	4.8e-05	8.53e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKT1—liver cancer	4.76e-05	8.47e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARA—liver cancer	4.71e-05	8.37e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CA—liver cancer	4.57e-05	8.13e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RAF1—liver cancer	4.54e-05	8.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MTOR—liver cancer	4.43e-05	7.87e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CB—liver cancer	4.43e-05	7.87e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HRAS—liver cancer	4.23e-05	7.52e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDKN1B—liver cancer	4.16e-05	7.39e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT1—liver cancer	4.11e-05	7.31e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CASP3—liver cancer	4.07e-05	7.24e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL2—liver cancer	4.07e-05	7.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—liver cancer	4.05e-05	7.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CG—liver cancer	4.03e-05	7.17e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCND1—liver cancer	3.96e-05	7.05e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JUN—liver cancer	3.96e-05	7.03e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CTNNB1—liver cancer	3.93e-05	6.98e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARG—liver cancer	3.89e-05	6.92e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—liver cancer	3.85e-05	6.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDKN1A—liver cancer	3.84e-05	6.82e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK8—liver cancer	3.74e-05	6.66e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT1—liver cancer	3.73e-05	6.64e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CD—liver cancer	3.54e-05	6.3e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—liver cancer	3.5e-05	6.22e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VEGFA—liver cancer	3.46e-05	6.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STAT3—liver cancer	3.42e-05	6.09e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CA—liver cancer	3.36e-05	5.97e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MYC—liver cancer	3.18e-05	5.65e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—liver cancer	3.17e-05	5.64e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CB—liver cancer	3.09e-05	5.49e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KRAS—liver cancer	2.94e-05	5.22e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKT1—liver cancer	2.74e-05	4.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CA—liver cancer	2.7e-05	4.8e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TP53—liver cancer	2.61e-05	4.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRAS—liver cancer	2.5e-05	4.44e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—liver cancer	2.39e-05	4.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT1—liver cancer	2.21e-05	3.92e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.88e-05	3.35e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKT1—liver cancer	1.54e-05	2.74e-05	CbGpPWpGaD
